Cyprus balcony fall man Sam Hudson to be discharged from hospital
He added: "Because of where it was broken, it was really hard to move my leg. I still can't really lift it up."I have to wiggle my foot and then use a hoist to sit up. I have to lift the bed and shuffle over to the wheelchair."Mr Hudson does not remember much about his holiday or the accident, but it is thought he was trying to climb from his bedroom balcony to his stepbrother's in the next room.The family set up a GoFundMe page to raise money to help with the costs and they said they would use the donations to fly him home with medical care.They are trying to arrange a flight in time for when he is discharged but fear if they cannot get one he may have to stay with his stepmother, Karen, at the flat where she has been staying in Cyprus, until one is arranged.Mr Hudson needs a wheelchair and the flat is not suitable to accommodate his needs.She said: "He still has broken bones and fractures."He's still got a wound from his surgery, which needs the dressing changing every four days and he can't go to the toilet by himself."He's a trooper, he's fighting through this. He's not on as many painkillers now (as he was). He's young and determined."
'Overwhelming support'
Karen said an operation to put pins in either side of his pelvis took seven hours and there was also a break where his leg joint connects to the hip.People have donated more than £5,000 to help the family, which she described as "overwhelming"."People we don't know are contacting us and saying the message is getting across to people. Be careful if you've been drinking and have a balcony on your hotel room. "If your friends have had one too many then put some furniture in the way so they can't get out on to the balcony either."Mr Hudson has urged people to take out holiday insurance and make sure they have signed up for a Global Health Insurance Card to get emergency help if needed.
Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Download the BBC News app from the App Store for iPhone and iPad or Google Play for Android devices
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
33 minutes ago
- Times
What the neuropsychologist did to slow her mother's dementia
Catherine Loveday, a professor of neuropsychology at the University of Westminster and author of The Secret World of the Brain, has dedicated her career to the study of memory. So when she suspected early signs of Alzheimer's in her 70-year-old mother, Scilla, she was well equipped to help. After tests in 2011 showed 'targeted memory loss' in keeping with the disease, Loveday says, 'it was so early in the progression I knew there were evidence-based steps we could take to slow it. I was in the most amazing position to have this knowledge and experience.' When Scilla was eventually diagnosed with mild Alzheimer's after a brain scan in 2017, she was 'upset but pragmatic', Loveday says. Now 85, Scilla's illness has progressed, but Loveday, 56, believes she still enjoys a better quality of life as a result of those early steps. 'In parallel, in my professional life, I have seen people whose dementia has progressed much quicker.' Their journey has proved 'hugely bonding', Loveday says, enabling a more open relationship with Scilla, who was herself an NHS psychiatrist. 'Her vulnerability was something I never saw. She's allowed me to feel I can be close to her and protect her.' Loveday, who lives in London with her sons, aged 23 and 18, and her husband, Jeff, 52, a composer, has now recorded a podcast, Mempathy, 'to show understanding the science can lead to a better quality of life and potentially even slow progression'. She has also developed Memory Matters, a four-week course for the charity Age UK with tips and activities to help anyone worried about their memory. Helping other families in their situation is her way of coping, she says. 'What I'm doing in my working life has come together with what I'm doing with my mum. My work has taught me that there are science-backed steps we can all take to improve our brain health — not only through more exercise, better diet and improved sleep, but by keeping the stress and anxiety that accompany memory loss under control, because these increase levels of inflammatory markers in the body that in turn may accelerate dementia.' • 12 things that can put you at risk of dementia While there can be a 'benign forgetfulness' in the elderly, by 2011 recently widowed Scilla was often repeating herself. She ran a choir at her local church but was 'getting muddled', Loveday says, and got lost on a regular walk, which 'made her scared'. Cambridge-educated Scilla had always been 'independent and resilient', Loveday, one of three sisters, says. Had she voiced concerns about Scilla's memory to her GP, Scilla may have been offered a mini-mental state examination, a ten-minute questionnaire used by doctors to assess cognitive impairment. But as a highly intelligent woman, she would have passed 'with flying colours', Loveday says. 'Mum would not have been picked up by the GP for another six or seven years.' Instead, she suggested her mum complete a more detailed hour-long 'battery' of tests used to test for dementia in NHS memory clinics, 'put together by a colleague with my input'. Loveday's intention was to assess 'a specific pattern of strengths and weaknesses'. When she explained this to her mum, she says Scilla 'was nervous but trusted me'. Scilla did well with some tasks. 'If I gave her a list of words, she could read them back,' Loveday says. Yet when she gave Scilla a list of words, read her a story and asked her to recall those words half an hour later, 'she was performing worse than 99.9 per cent of people'. Scilla's prefrontal cortex — the area of the brain responsible for problem-solving — was working well but her hippocampus, which deals with memory and is usually the first affected by Alzheimer's, was not. 'What I was seeing was the early signature of Alzheimer's disease,' Loveday says. Her fear at her findings was tinged with 'relief' that 'we could do something about it'. • Read more expert advice on healthy living, fitness and wellbeing She gently told her mother 'a specific memory score was down in her test, which might explain why she was having difficulty in day-to-day life'. She was careful not to mention the disease by name at first, but when Scilla took the same test 18 months later her scores suggested 'a progressive condition like Alzheimer's'. After a subsequent hospital assessment in 2013 Scilla was diagnosed with mild cognitive impairment — a decline in cognitive function, for which there is no medical treatment, and from which, according to the NHS, 10-15 per cent of sufferers will develop dementia each year. Yet awareness of her condition empowered mother and daughter. 'It's felt like a shared project,' Loveday says. 'The measures we took have slowed decline but her Alzheimer's obviously continues to progress. Mum now has limited access to her past memories, but the work we did means we know exactly what makes her feel happy and we put that into practice every day. Last time I was with her, I asked, 'How do you feel?' and she said, 'Relaxed and at peace,' and I don't think we can ask for more. We were able to really make a difference.' Here's how. Scilla immediately started writing a journal of everything she could remember doing that day before bed. She would read what she'd written the previous evening before writing the next entry. By leaving 24-hour gaps between reading the information again she was practising 'spaced repetition', Loveday says, a learning technique that improves memory by reviewing information at intervals. For Scilla, who wrote her diary for eight years until her memory became too weak, it was 'transformational', Loveday says. Scilla's social life needed to be adapted. 'Book club was not working, because she couldn't remember what she was reading,' Loveday says, 'but going for a walk with people, playing online Scrabble or going for a cup of tea were good.' Scilla still sees friends at least once a week. Maintaining friendships is key to healthy cognitive function, Loveday says, because they can lower stress and so reduce inflammation in the brain that can be a precursor to Alzheimer's and is 'known to impact on progression'. • Want to stay sharp? How curiosity can boost the midlife brain Scilla and Loveday labelled the contents of cupboards so Scilla didn't forget where food was. Loveday bought her mum a dementia clock with the time and date in big letters and hung a white memory board with a pen in the kitchen. 'Each day she would make a note of things she had to remember to do. We made it a habit.' Loveday taught Scilla how to use Google Maps on her smartphone. Just knowing it was there 'made her more relaxed', she says. 'One of the worst things you can do when you're lost is panic.' She also started tracking her mum on iPhone's Find My app, 'so if she was stuck we could help'. Scilla's early memories were strong, which is 'typical' in early Alzheimer's, Loveday says. Sparking conversation about them with questions — or 'cues' — can help preserve identity. Recalling her 'scratchy' school uniform, for example, brought up stories about Scilla's schooling. Another good cue is music. 'I know from my research if you ask people to give their eight favourite songs, often one or two will prompt memories about a specific moment that was transitional or important in terms of who you became,' Loveday says. 'Nostalgic conversations are powerful social connectors.' Once a keen squash player, Scilla walked every day until Covid, when it was harder to get out. 'She now has limited mobility, which is partly a reflection of the progression of the disease and partly because she wasn't able to keep up the same level of exercise.' There is evidence that exercise improves brain-derived neurotrophic factor, a protein that supports cognitive function, Loveday says, and simply leaving the house can help because 'navigating stimulates the hippocampus. From an evolutionary point of view, the memory systems switch on because you need to find your way back to safety.' • 'They thought Dad was depressed. It was rare type of dementia' Scilla increased her intake of foods that contain flavanols and polyphenols — plant compounds 'which are probably supportive to brain health', Loveday says — such as berries and dark green vegetables and cut out sugary snacks to avoid glucose spikes, which are shown to reduce cognitive function. 'There is a comorbidity with dementia and diabetes.' She started taking fish oil and vitamin B supplements because there was 'some evidence they might support brain function' and Loveday encouraged her mum to keep to a stricter bedtime routine. While Alzheimer's sufferers often struggle to sleep, some evidence suggests improved sleep quality can improve progression. Loveday and her sisters ascertained their mum's wishes for her future care early on. This can be upsetting and 'we had to be gentle', Loveday says. She learnt that Scilla's main priority was remaining in her home in Devon, which she does, with the help of a carer since 2020. 'She was clear she didn't want any of her daughters to be giving up their life for her and it's helpful to have had that conversation.' Anyone struggling with recall should have their eyesight and hearing tested regularly — the NHS recommends annual hearing tests and eyesight tests every two years for those over 60 — because 'the richness of our sensory world impacts on memory', Loveday says. Although Scilla's hearing is 'brilliant' there is evidence that hearing impairment is linked with cognitive decline. 'We don't 100 per cent know why but it seems to be about social connection. If you can get hearing aids that reduces that.' Mempathy is available on Spotify
Times
33 minutes ago
- Times
The experts' guide to the probiotics that work
P robiotics, the 'gut-friendly' supplements and functional foods that purportedly transform your health, immunity and mental wellbeing, are part of a market worth £178 million — and rising. By 2035 it is estimated we will be spending £242 million on tending to our microbiome, the vast ecosystem of bacteria, fungi and yeasts that inhabit our intestines. But what happens when these products are subjected to scientific scrutiny of the highest order — do they really live up to their claims? Until now consumers had no way of telling if the probiotic pill they were popping was worth taking or better left on the shelf. 'The probiotic market has exploded, but choosing the right product remains incredibly challenging,' says Dr Gemma Walton, a researcher at the University of Reading's department of food and nutritional sciences. 'Well-researched products sit on the shelves next to others that may have very little research behind them.'
Daily Mail
2 hours ago
- Daily Mail
Boost for AstraZeneca after successful trial of experimental blood pressure drug
Shares in AstraZeneca rose after a successful trial of a blood pressure drug. Britain's biggest listed firm said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of hypertension. AstraZeneca said it expects its annual sales for the drug to top £3.7billion. Hypertension, known as high blood pressure, affects more than 1bn globally, according to the World Health Organisation. The condition can cause heart attacks or strokes. In the late-stage trial, the drug met its main and secondary goals to show a significant reduction in systolic blood pressure at 12 weeks, when compared with a placebo treatment, AstraZeneca said. It is different to older treatments, including ACE inhibitors, as it targets aldosterone, a hormone that raises blood pressure, the company said. The drug maker bought Baxdrostat through its £1.3billion takeover of CinCor Pharma in 2023. This was part of the group's strategy to expand its treatments for heart and kidney disease. Dan Coatsworth, investment analyst at AJ Bell, said: 'Phase three drug trials are the most important events for pharmaceutical companies as they're make or break time. 'It's the final test to see if a treatment is effective and can be submitted to a regulator for approval. AstraZeneca hit the jackpot with its hypertension drug trial.' AstraZeneca shares rose 2 per cent, or 212p, to 10,662p. Reports this month suggested it is considering shifting its stock market listing to the US in what would be a major blow to the London exchange. Chief executive Pascal Soriot is reportedly weighing moving the headquarters away from the UK as well as its main stock market listing. Soriot, 66, has lambasted the UK and the rest of Europe for falling behind other countries such as the US and China in developing medicines. In April, he said that innovation in pharmaceuticals 'has mostly been funded by the US'.
